MGRX (Mangoceuticals) EBIT per Share : $-5.63 (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals EBIT per Share?

Mangoceuticals's EBIT per Share for the three months ended in Sep. 2024 was $-0.87. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-5.63.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Mangoceuticals's EBIT per Share or its related term are showing as below:

MGRX's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.25
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Mangoceuticals's EBIT for the three months ended in Sep. 2024 was $-1.76 Mil.

Mangoceuticals EBIT per Share Historical Data

The historical data trend for Mangoceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals EBIT per Share Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

-1.95

-8.58

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial							-1.69	-1.96	-1.56	-1.25	-0.87

Mangoceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Mangoceuticals's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.212	/	1.074
=	-8.58

Mangoceuticals's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.758	/	2.014
=	-0.87

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.63

Mangoceuticals (NAS:MGRX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Mangoceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Executives

Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506
Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248